On April 11, 2016, Dr. Niu Lizhi, the President of Guangzhou Fuda Cancer Hospital, visited previous cancer patients of Fuda Cancer Hospital in Jakarta after attending ASEAN (International) Forum on Intestine Cancer Treatment in Bali. Affra Siowardjaja (born in May 6, 1956), who suffered from stage IV breast cancer with bone metastases, have survived 12 years without recurrence after receiving comprehensive treatments that include cryosurgery, chemotherapy and repair surgery, chemotherapy and immunotherapy at FUDA in 2004.
Breast cancer patient Mary Laurensia, born in August 6, 1969, was found to have a breast mass in 2007 but she did not pay any attention to it. In 2008, the mass was found to have grown bigger especially after the pathological examination, which confirmed that she suffered from Stage III breast cancer. She has survived 8 years without recurrence after receiving argon-helium cryosurgery, 6 cycles of chemotherapy, 35 sessions of radiotherapy and endocrine therapy for three years.
Prostate cancer patient Fachrutdin Tjoe, born on August 4, 1947, has survived 7 years without recurrence after receiving argon-helium cryosurgery, interventional chemotherapy in 2009. Oral and liver lymphoma Yana Sari Putri Sihombing, born on January 4, 1079, has survived 7 years without recurrence after receiving argon-helium cryosurgery and chemotherapy at FUDA in 2009.
Anal canal carcinoma patient Tan Hong Som, born on December 4, 1950, has his anus successfully preserved after receiving PDT (photodynamic therapy), interventional chemotherapy and CIC (combined immunotherapy for cancer) at FUDA instead of going through colostomy in other hospital. Patient has survived 5 years without recurrence and enjoyed high-quality life with the anus in situ since the treatment.
Pancreatic cancer patient Litasari Karwita, female, 55 years old, has been enjoying a stable condition since treatment three years ago. Kidney cancer patient Henry Widjaja, male, 52 years old, has successfully had his kidney preserved after undergoing argon-helium cryosurgery.
Advanced uterus cancer patient Yang Chunmei, 80 years old, has survived almost 10 years after going through interventional chemotherapy, photodynamic therapy, argon-helium cryosurgery and immunotherapy at FUDA in 2007.
Lung cancer patient Dr. Tjan Kian Seng, male, 83 years old, has survived 5 years after undergoing one single cycle of cryosurgery. Liver cancer patient Zhong Guoqing, male, 71 years old, has survived 6 years without recurrence after receiving argon-helium cryosurgery and interventional embolization in early 2010. Some of the above-mentioned patients were not be able to present at the lecture due to private affairs but all of them expressed their appreciation to Dr. Niu Lizhi for coming all the long way to visit them.
Dr. Niu Lizhi noted that cancer is still a world problem. Though new drugs and new technologies are emerging by each passing day, patients cannot make progress on their anti-cancer journey without their own persistence, the encouragement and support from the family members and the rational application of innovative treatments by the doctors. Fuda Cancer Hospital has adopted the latest technology for cancer –NanoKnife, which has proven to be effective in treating pancreatic cancer, liver cancer, etc. During the procedure, high electric-field and ultrashort pulses are given to destroy lipid bilayer structure of cancer cell membrane and form numerous irreversible nano-sized pores in the cell membrane. Tumor cell death is induced while surrounding nerves, blood vessels, intestinal canals, bile duct remain intact. Doctors at FUDA hope to bring about more survival benefits for cancer patients with the latest technology. After met with previous patient, Dr. Niu provided free consultation for new diagnosed cancer patients who come all the long way to him.
From left: chief editor Li Zhuohui, breast cancer survivor Mary Laurensia, and Dr. Niu Lizhi
From left: liver cancer survivor Marison Pangadean Siagian, chief editor Li Zhuohui, prostate cancer survivor Fachrutdin Tjoe, Dr. Liu Zhengping
